What Are Some Concerns Regarding Pre-Exposure Prophylaxis Treatment?
JUN 14, 2017 | CONTAGION® EDITORIAL STAFF
Kenneth Mayer, MD, Medical Research Director, Professor of Medicine, Fenway Health, Harvard University, shares some of the common concerns individuals have regarding the use of pre-exposure prophylaxis as protection against HIV.
Interview Transcript (slightly modified for readability)
“Pre-exposure prophylaxis is the use of antiretroviral medications to protect people against HIV; it’s shown to be effective if people are adherent. So, the concerns are some people might be prescribed this and not be adherent, and they could become infected, [and] not have adequate drug levels on board but select for drug resistance. Others have concerns just about the idea of giving medication to people who are otherwise healthy, but we think of this as a very important way to prevent HIV.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
We break down our top HIV news stories of 2017. Did you read them all?
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512